GELSOMINO, FRANCESCO

GELSOMINO, FRANCESCO  

DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE  

Collaboratori  

Risultati 1 - 20 di 27 (tempo di esecuzione: 0.025 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
18F-FLT PET/CT in patients with advanced Non-Small Lung Cancer (NSCLC) treated with Nivolumab: preliminary results G Polverari, V Ambrosini, F Gelsomino, S Diodato, F Ceci, F Sperandi, A Ardizzoni, S Fanti 2016-01-01 EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING - 4.02 Riassunto (Abstract) -
Anti-programmed cell death-1 and anti-programmed cell death ligand-1 immune-related liver diseases: from clinical pivotal studies to real-life experience Vitale G.; Lamberti G.; Comito F.; Di Nunno V.; Massari F.; Morelli M.C.; Ardizzoni A.; Gelsomino F. 2020-01-01 EXPERT OPINION ON BIOLOGICAL THERAPY - 1.01 Articolo in rivista -
Arterial Embolization During Programmed Death-1 Inhibitor Treatment: An Unexpected Finding Dall'Olio, Filippo Gustavo; Sperandi, Francesca; Rihawi, Karim; Gargiulo, Mauro; Melotti, Barbara; Brocchi, Stefano; Gelsomino, Francesco*; Ardizzoni, Andrea 2018-01-01 JOURNAL OF THORACIC ONCOLOGY - 1.01 Articolo in rivista -
Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial) Gelsomino F.; Lamberti G.; Tiseo M.; Rocco D.; Pasello G.; Cecere F.L.; Chella A.; Grilli G.; Mandruzzato M.; Tognetto M.; Garassino M.C.; Macerelli M.; Novello S.; Roila F.; Colantonio I.; Grossi F.; Fiorentino M.; Ardizzoni A. 2020-01-01 THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY - 1.01 Articolo in rivista Gelsomino_CHANCE_TAMO'20.pdf
Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma Lamberti G.; Andrini E.; Sisi M.; Rizzo A.; Parisi C.; Di Federico A.; Gelsomino F.; Ardizzoni A. 2020-01-01 CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY - 1.01 Articolo in rivista -
A case of nivolumab-related cholangitis and literature review: how to look for the right tools for a correct diagnosis of this rare immune-related adverse event Gelsomino, Francesco*; Vitale, Giovanni; Ardizzoni, Andrea 2018-01-01 INVESTIGATIONAL NEW DRUGS - 1.01 Articolo in rivista -
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC Mazzaschi, Giulia; Facchinetti, Francesco; Missale, Gabriele; Canetti, Diana; Madeddu, Denise; Zecca, Alessandra; Veneziani, Michele; Gelsomino, Francesco; Goldoni, Matteo; Buti, Sebastiano; Bordi, Paola; Aversa, Franco; Ardizzoni, Andrea; Quaini, Federico; Tiseo, Marcello 2019-01-01 LUNG CANCER - 1.01 Articolo in rivista -
Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab Facchinetti, Francesco*; Veneziani, Michele; Buti, Sebastiano; Gelsomino, Francesco; Squadrilli, Anna; Bordi, Paola; Bersanelli, Melissa; Cosenza, Agnese; Ferri, Leonarda; Rapacchi, Elena; Mazzaschi, Giulia; Leonardi, Francesco; Quaini, Federico; Ardizzoni, Andrea; Missale, Gabriele; Tiseo, Marcello 2018-01-01 IMMUNOTHERAPY - 1.01 Articolo in rivista -
Complete Recalcification Following Arterial Embolization of Massive Osteolytic Bone Metastasis From NSCLC Francesco Gelsomino,Giancarlo Facchini, Maria Aurelia Barbera, Giuseppe Lamberti, Stefano Brocchi, Giuseppe Rossi, Andrea Ardizzoni 2019-01-01 JOURNAL OF THORACIC ONCOLOGY - 1.01 Articolo in rivista -
Evolution of cystic airspaces lung lesions on immune checkpoint inhibition in non-small cell lung cancer Parisi C.; Lamberti G.; Zompatori M.; Gelsomino F.; Salvagni S.; Sperandi F.; Ardizzoni A. 2020-01-01 JOURNAL FOR IMMUNOTHERAPY OF CANCER - 1.01 Articolo in rivista Parisi_Cystic airspaces_JIC'20.pdf
The evolving landscape of immunotherapy in small-cell lung cancer: A focus on predictive biomarkers Gelsomino, Francesco; Lamberti, Giuseppe; Parisi, Claudia; Casolari, Laura; Melotti, Barbara; Sperandi, Francesca; Ardizzoni, Andrea 2019-01-01 CANCER TREATMENT REVIEWS - 1.01 Articolo in rivista -
IFN-γ and CD38 in Hyperprogressive Cancer Development Angelicola, Stefania; Ruzzi, Francesca; Landuzzi, Lorena; Scalambra, Laura; Gelsomino, Francesco; Ardizzoni, Andrea; Nanni, Patrizia; Lollini, Pier-Luigi; Palladini, Arianna 2021-01-01 CANCERS - 1.01 Articolo in rivista CD38 cancers-13-00309-v2.pdf
Immune-mediated cholangitis: is it always nivolumab’s fault? Gelsomino, Francesco*; Vitale, Giovanni; Ardizzoni, Andrea 2018-01-01 CANCER IMMUNOLOGY, IMMUNOTHERAPY - 1.01 Articolo in rivista -
KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC Cinausero M.; Laprovitera N.; Maglio G.D.; Gerratana L.; Riefolo M.; Macerelli M.; Fiorentino M.; Porcellini E.; Buoro V.; Gelsomino F.; Squadrilli A.; Fasola G.; Negrini M.; Tiseo M.; Ferracin M.; Ardizzoni A. 2019-01-01 THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY - 1.01 Articolo in rivista 2019_Immunotherapy.pdf
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance Raschi E.; Gatti M.; Gelsomino F.; Ardizzoni A.; Poluzzi E.; De Ponti F. 2020-01-01 TARGETED ONCOLOGY - 1.01 Articolo in rivista ICI_Targeted_Oncology_2020.pdf11523_2020_738_MOESM1_ESM.pdf
The mechanisms of PD-L1 regulation in non-small-cell lung cancer (NSCLC): Which are the involved players? Lamberti G.; Sisi M.; Andrini E.; Palladini A.; Giunchi F.; Lollini P.-L.; Ardizzoni A.; Gelsomino F. 2020-01-01 CANCERS - 1.01 Articolo in rivista Lamberti_PDL1_cancers-12-03129.pdf
New disappearance of complicated atheromatous plaques on rechallenge with PD-1/PD-L1 axis blockade in non-small cell lung cancer patient: follow up of an unexpected event Lamberti G.; Gelsomino F.; Brocchi S.; Poerio A.; Melotti B.; Sperandi F.; Gargiulo M.; Borghi C.; Fiorentino M.; Ardizzoni A. 2020-01-01 THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY - 1.01 Articolo in rivista Lamberti_atheromatous plaque_TAMO'20.pdf
Next-generation technologies in predictive molecular pathology of lung cancers de Biase, Dario; Maloberti, Thais; De Leo, Antonio; Sanza, Viviana; Visani, Michela; Gruppioni, Elisa; Altimari, Annalisa; Grillini, Alessia; Gelsomino, Francesco; Ferrari, Marco; Ardizzoni, Andrea; Tallini, Giovanni 2022-01-01 Journal of Xiangya Medicine - 1.01 Articolo in rivista -
Nivolumab-induced cholangitic liver disease: A novel form of serious liver injury Gelsomino, F; Vitale, G.; D'Errico, A.; Bertuzzi, C.; Andreone, P.; Ardizzoni, A. 2017-01-01 ANNALS OF ONCOLOGY - 1.01 Articolo in rivista -
Overcoming Primary Resistance to PD-1 Inhibitor With Anti–PD-L1 Agent in Squamous-Cell NSCLC: Case Report Gelsomino F.; Di Federico A.; Filippini D.M.; Dall'Olio F.G.; Lamberti G.; Sperandi F.; Balacchi C.; Brocchi S.; Ardizzoni A. 2020-01-01 CLINICAL LUNG CANCER - 1.01 Articolo in rivista -